Guarding against immune responses limiting efficacy of antibody-based approaches to HIV
Wednesday, December 30, 2015 - 19:00
in Health & Medicine
Immunogeneticists specializing in immunoglobulin GM genes monitored for immune responses that could limit the effectiveness of the broadly neutralizing antibody VRC01 in HIV-infected individuals in a phase 1 trial.